Brainlab AG recalls ExacTrac Vero is a Patient Positioning System for Radiation therapy.
- Recall date
- May 4, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-1929-2016
- FDA classification
- Class II
- Brand / firm
- Brainlab AG
- Sold / distributed
- Distributed in the states of Florida, New York, Texas and Ohio, and in the countries of Belgium, France, Germany, Italy, Japan and South Korea.
Why it was recalled
Potentially incorrect positioning when using Implanted Marker Detection with Brainlab ExacTrac Vero 3.5
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
ExacTrac Vero is a Patient Positioning System for Radiation therapy.
Get recall alerts
Free email alert whenever Brainlab AG has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Brainlab AG